CL2016001900A1 - Sobreexpresión de los reguladores de caminos de n-glicosilación para regular la glicosilación de proteinas recombinante - Google Patents

Sobreexpresión de los reguladores de caminos de n-glicosilación para regular la glicosilación de proteinas recombinante

Info

Publication number
CL2016001900A1
CL2016001900A1 CL2016001900A CL2016001900A CL2016001900A1 CL 2016001900 A1 CL2016001900 A1 CL 2016001900A1 CL 2016001900 A CL2016001900 A CL 2016001900A CL 2016001900 A CL2016001900 A CL 2016001900A CL 2016001900 A1 CL2016001900 A1 CL 2016001900A1
Authority
CL
Chile
Prior art keywords
glycosylation
overexpression
recombinant protein
pathway regulators
regulate recombinant
Prior art date
Application number
CL2016001900A
Other languages
English (en)
Inventor
Sohye Kang
Shivani Gupta
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53757626&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2016001900(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of CL2016001900A1 publication Critical patent/CL2016001900A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01101—Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (2.4.1.101)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01143—Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (2.4.1.143)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01094—Protein N-acetylglucosaminyltransferase (2.4.1.94)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

Sobreexpresión de los reguladores de una ruta de n-glicosilación para regular la glicosilación de proteinas recombinante durante un proceso de cultivo de células de mamífero.
CL2016001900A 2014-01-29 2016-07-26 Sobreexpresión de los reguladores de caminos de n-glicosilación para regular la glicosilación de proteinas recombinante CL2016001900A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461933137P 2014-01-29 2014-01-29

Publications (1)

Publication Number Publication Date
CL2016001900A1 true CL2016001900A1 (es) 2017-05-12

Family

ID=53757626

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016001900A CL2016001900A1 (es) 2014-01-29 2016-07-26 Sobreexpresión de los reguladores de caminos de n-glicosilación para regular la glicosilación de proteinas recombinante

Country Status (14)

Country Link
US (3) US10227627B2 (es)
EP (1) EP3099806A1 (es)
JP (4) JP6474420B2 (es)
KR (3) KR102519540B1 (es)
CN (2) CN113774084B (es)
AU (3) AU2014380174C1 (es)
BR (1) BR112016017606A2 (es)
CA (1) CA2938079C (es)
CL (1) CL2016001900A1 (es)
EA (2) EA202190244A3 (es)
IL (3) IL282517B (es)
MX (2) MX377780B (es)
SG (1) SG10201912081RA (es)
WO (1) WO2015116315A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101936049B1 (ko) * 2015-10-15 2019-01-08 (주)알테오젠 IgG Fc 도메인을 가지는 융합 단백질의 생산방법
US12503700B2 (en) * 2017-03-14 2025-12-23 Amgen Inc. Control of total afucosylated glycoforms of antibodies produced in cell culture
IL307155B2 (en) 2018-05-01 2025-11-01 Amgen Inc Antibodies with modulated glycan profiles
CN109576212B (zh) * 2018-12-14 2021-06-22 杭州奕安济世生物药业有限公司 高密度接种培养中种子细胞的培养方法及其应用
IL288877B2 (en) * 2019-06-10 2024-05-01 Cho Plus Inc Cell lines for high-level production of protein-based drugs
AU2022262421A1 (en) 2021-04-23 2023-10-19 Amgen Inc. Anti-tslp antibody compositions and uses thereof
WO2022233770A1 (en) * 2021-05-03 2022-11-10 Boehringer Ingelheim International Gmbh Method for producing spesolimab
CN113684322B (zh) * 2021-09-09 2024-01-23 上海药明生物技术有限公司 一种降低抗体类蛋白高聚甘露糖型水平的方法
CN114525252B (zh) * 2022-03-10 2023-12-01 广州源井生物科技有限公司 一种提高mda-mb-231单细胞克隆形成率的单克隆增强培养基与培养方法及其应用
UY40500A (es) 2022-10-26 2024-04-30 Amgen Inc Composiciones de anticuerpos anti-tslp y usos de las mismas

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
AU588819B2 (en) 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
US5672502A (en) 1985-06-28 1997-09-30 Celltech Therapeutics Limited Animal cell culture
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
WO1990005183A1 (en) 1988-10-31 1990-05-17 Immunex Corporation Interleukin-4 receptors
US5395760A (en) 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
EP1132471A3 (de) 1989-09-12 2001-11-28 F. Hoffmann-La Roche Ag TNF-bindende Proteine
US6204363B1 (en) 1989-10-16 2001-03-20 Amgen Inc. Stem cell factor
US5149792A (en) 1989-12-19 1992-09-22 Amgen Inc. Platelet-derived growth factor B chain analogs
US5272064A (en) 1989-12-19 1993-12-21 Amgen Inc. DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
WO1991018982A1 (en) 1990-06-05 1991-12-12 Immunex Corporation Type ii interleukin-1 receptors
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
GB9014932D0 (en) 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
JPH05244982A (ja) 1991-12-06 1993-09-24 Sumitomo Chem Co Ltd 擬人化ｂ−ｂ１０
ATE240394T1 (de) 1992-10-23 2003-05-15 Immunex Corp Methoden zur herstellung löslicher, oligomerer proteine
US5981713A (en) 1994-10-13 1999-11-09 Applied Research Systems Ars Holding N.V. Antibodies to intereleukin-1 antagonists
ES2253753T3 (es) 1995-06-29 2006-06-01 Immunex Corporation Citocina que induce apoptosis.
US6613544B1 (en) 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US6096728A (en) 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
US6235883B1 (en) 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
US6337072B1 (en) 1998-04-03 2002-01-08 Hyseq, Inc. Interleukin-1 receptor antagonist and recombinant production thereof
AU1920301A (en) 1999-11-17 2001-05-30 Immunex Corporation Receptor activator of nf-kappa b
GB9928787D0 (en) 1999-12-03 2000-02-02 Medical Res Council Direct screening method
US6544424B1 (en) 1999-12-03 2003-04-08 Refined Technology Company Fluid filtration system
GB0025144D0 (en) 2000-10-13 2000-11-29 Medical Res Council Concatenated nucleic acid sequences
US20040202995A1 (en) 2003-04-09 2004-10-14 Domantis Nucleic acids, proteins, and screening methods
US20050186577A1 (en) * 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
AU2005229359C1 (en) 2004-03-05 2011-07-28 Patheon Holdings I B.V. Process for cell culturing by continuous perfusion and alternating tangential flow
AU2005289685B2 (en) 2004-09-24 2009-07-16 Amgen Inc. Modified Fc molecules
US8053238B2 (en) 2005-10-31 2011-11-08 Unhwa Corporation Isolated population of plant single cells and method of preparing the same
US20070190057A1 (en) * 2006-01-23 2007-08-16 Jian Wu Methods for modulating mannose content of recombinant proteins
US20100145032A1 (en) * 2007-01-18 2010-06-10 Suomen Punainen Risti, Veripalelu Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof
US20100221823A1 (en) * 2007-06-11 2010-09-02 Amgen Inc. Method for culturing mammalian cells to improve recombinant protein production
TW201028431A (en) * 2008-10-31 2010-08-01 Lonza Ag Novel tools for the production of glycosylated proteins in host cells
CA2757079C (en) * 2009-04-20 2015-05-19 Pfizer Inc. Control of protein glycosylation and compositions and methods relating thereto
US20130196410A1 (en) * 2010-03-05 2013-08-01 Alnylam Pharmaceuticals, Inc Compositions and methods for modifying the glycosylation pattern of a polypeptide
US9921210B2 (en) * 2010-04-07 2018-03-20 Momenta Pharmaceuticals, Inc. High mannose glycans
TW201209160A (en) * 2010-04-27 2012-03-01 Lonza Ag Improved glycosylation of proteins in host cells
WO2012145682A1 (en) 2011-04-21 2012-10-26 Amgen Inc. A method for culturing mammalian cells to improve recombinant protein production
CN110438083A (zh) 2012-01-11 2019-11-12 西格马-奥尔德里奇有限责任公司 具有简单糖型的重组蛋白的产生

Also Published As

Publication number Publication date
CN113774084A (zh) 2021-12-10
CA2938079A1 (en) 2015-08-06
CA2938079C (en) 2022-10-11
JP2022068365A (ja) 2022-05-09
JP6797950B2 (ja) 2020-12-09
AU2018264100C1 (en) 2025-06-05
BR112016017606A2 (pt) 2017-10-10
CN106170554B (zh) 2021-08-17
JP2019088305A (ja) 2019-06-13
JP7788307B2 (ja) 2025-12-18
MX377780B (es) 2025-03-11
US20190010532A1 (en) 2019-01-10
SG10201912081RA (en) 2020-02-27
AU2020239681B2 (en) 2022-06-23
JP2021040638A (ja) 2021-03-18
AU2014380174C1 (en) 2025-06-05
EA202190244A3 (ru) 2021-08-31
US10227627B2 (en) 2019-03-12
EA201691532A1 (ru) 2017-01-30
IL270861A (en) 2020-01-30
US10907186B2 (en) 2021-02-02
US10655156B2 (en) 2020-05-19
JP2017505620A (ja) 2017-02-23
KR20210114549A (ko) 2021-09-23
CN113774084B (zh) 2024-04-16
EP3099806A1 (en) 2016-12-07
AU2018264100A1 (en) 2018-12-06
AU2018264100B2 (en) 2020-07-23
MX2020012356A (es) 2021-01-29
KR102410393B1 (ko) 2022-06-16
JP6474420B2 (ja) 2019-02-27
US20200277642A1 (en) 2020-09-03
IL270861B (en) 2021-05-31
MX2016009911A (es) 2016-10-28
IL246914A0 (en) 2016-09-29
JP7034236B2 (ja) 2022-03-11
KR102301034B1 (ko) 2021-09-13
AU2020239681A1 (en) 2020-10-15
IL246914B (en) 2019-12-31
WO2015116315A1 (en) 2015-08-06
KR20160111943A (ko) 2016-09-27
EA202190244A2 (ru) 2021-05-31
IL282517A (en) 2021-06-30
KR20220086703A (ko) 2022-06-23
EA037565B1 (ru) 2021-04-14
CN106170554A (zh) 2016-11-30
KR102519540B1 (ko) 2023-04-10
AU2014380174B2 (en) 2018-08-30
AU2014380174A1 (en) 2016-08-11
AU2020239681C1 (en) 2025-06-05
US20190153496A1 (en) 2019-05-23
IL282517B (en) 2022-07-01

Similar Documents

Publication Publication Date Title
CL2016001900A1 (es) Sobreexpresión de los reguladores de caminos de n-glicosilación para regular la glicosilación de proteinas recombinante
IL285543A (en) Modified natural killer (nk) cells for immunotherapy
CY1121217T1 (el) Μεθοδοι για συγκομιδη καλλιεργειων κυτταρου θηλαστικων
IL268525A (en) Mammalian cells for producing adeno-associated viruses
MX2023008559A (es) Proteínas de fusión fc heterodiméricas il15/il15ra.
EA201692025A1 (ru) Доставка белков, осуществляемая на основе бактерий
GEAP202114450A (en) Anti-tigit antibodies
MX373660B (es) Fibroblastos de embrion de pollo inmortalizados.
AR095075A1 (es) Acoplamiento electroquímico de anilinas
HUE063273T2 (hu) Heteromultimer fehérjék elõállítása emlõssejtek felhasználásával
EP3448884C0 (en) Engineered mammalian cells for production of recombinant proteins
DK3743266T3 (da) 3D-bioprintere med midler til cellekulturovervågning
MX2018004005A (es) Ensayo de potencia celular.
MX2018007298A (es) Variantes con mejores propiedades de polipéptidos de fusión relacionados con omega-hidroxilasa.
EP4083186A4 (en) Cell growth regulator
EP3107934A4 (en) Enhancement of recombinant protein expression using a membrane-based cell retention system
MY168269A (en) Power supply system
GEP20186831B (en) Method for pipeline sedimentation waste-free utilization
UA95310U (uk) Спосіб підвищення інкубаційних якостей яєць перепелів
RU2013150974A (ru) Способ культивирования личинок нематод подотряда ascaridata
RU2014134753A (ru) Ген PDGF-Bopt тромбоцитарного фактора роста человека
UA97346U (en) Method for increasing the antioxidant protection of quails with aquachelate solution of selenium